LD1018

Prevents discrimination against 340B drug discount program participants by manufacturers and insurers.

Prohibits pharmaceutical manufacturers, health insurance carriers, pharmacy benefits managers, and their agents from discriminating against pharmacies and health care providers participating in the federal 340B drug discount program. Prohibited actions include interfering with drug acquisition or delivery, requiring data submission, imposing additional fees or restrictions, and excluding 340B entities from networks. The bill also prevents insurers from reimbursing 340B entities at lower rates and from imposing different terms and conditions.